Literature DB >> 9473090

Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection.

Y Kato1, D Yu, M Z Schwartz.   

Abstract

BACKGROUND/
PURPOSE: Hepatocyte growth factor (HGF), originally known to stimulate hepatocyte DNA synthesis, also has been shown to stimulate growth of intestinal epithelial cells in vitro. The authors recently demonstrated that HGF can dramatically increase substrate absorption beyond the normal adaptive response after massive small bowel resection in the rat. However, the mechanism for this enhanced substrate absorption is unknown. This study was designed to determine if up-regulation of gene expression by HGF of the Na+/glucose cotransporter SGLT1 and the facilitative glucose transporter GLUT5 is a possible mechanism of action.
METHODS: Young adult Sprague-Dawley rats underwent an 80% small bowel resection and jejunostomy tube placement. Seven days later, an osmotic minipump was connected to the subcutaneously placed jejunostomy tube. The rats were divided into two groups based on the contents in the minipumps: group 1, saline (control, n = 5); and group 2, HGF at 75 microg/kg/d (n = 5). After a 14-day infusion, biopsy specimens of the small bowel mucosa were obtained. After total RNA extraction, Northern blot analysis was performed with SGLT1 and GLUT5 cDNA probes. Auto radiographs were quantitated by image analysis.
RESULTS: SGLT1 mRNA levels were significantly up-regulated in the HGF-treated animals (121% increase, P<.01) when compared with the control. Up-regulation of GLUT5 mRNA levels was also seen in the HGF-treated animals (96% increase, P < .01).
CONCLUSIONS: These data, demonstrating that HGF upregulates intestine epithelial glucose transporter gene expression after massive small bowel resection, may elucidate a mechanism of action for the enhanced carbohydrate absorption after HGF administration. This growth factor may be useful for patients with short bowel syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473090     DOI: 10.1016/s0022-3468(98)90351-7

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  9 in total

1.  Growth hormone stimulates remnant small bowel epithelial cell proliferation.

Authors:  Xin Zhou; Ning Li; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Small bowel review: normal physiology part 1.

Authors:  A B Thomson; M Keelan; A Thiesen; M T Clandinin; M Ropeleski; G E Wild
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 3.  Intestinal adaptation after massive intestinal resection.

Authors:  A R Weale; A G Edwards; M Bailey; P A Lear
Journal:  Postgrad Med J       Date:  2005-03       Impact factor: 2.401

4.  Hepatocyte growth factor is a novel stimulator of glucose uptake and metabolism in skeletal muscle cells.

Authors:  German Perdomo; Maria A Martinez-Brocca; Bankim A Bhatt; Nicholas F Brown; Robert M O'Doherty; Adolfo Garcia-Ocaña
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

Review 5.  Novel therapies for the management of short bowel syndrome in children.

Authors:  Marshall Z Schwartz
Journal:  Pediatr Surg Int       Date:  2013-10       Impact factor: 1.827

6.  Targeted delivery of HGF to the skeletal muscle improves glucose homeostasis in diet-induced obese mice.

Authors:  Viviana Sanchez-Encinales; Irene Cozar-Castellano; Adolfo Garcia-Ocaña; Germán Perdomo
Journal:  J Physiol Biochem       Date:  2015-10-27       Impact factor: 4.158

Review 7.  The Role of Hepatocyte Growth Factor (HGF) in Insulin Resistance and Diabetes.

Authors:  Alexandre G Oliveira; Tiago G Araújo; Bruno de Melo Carvalho; Guilherme Z Rocha; Andrey Santos; Mario J A Saad
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-30       Impact factor: 5.555

8.  The protective effects of hepatocyte growth factor on the intestinal mucosal atrophy induced by total parenteral nutrition in a rat model.

Authors:  Koshiro Sugita; Tatsuru Kaji; Keisuke Yano; Makoto Matsukubo; Ayaka Nagano; Mayu Matsui; Masakazu Murakami; Toshio Harumatsu; Shun Onishi; Koji Yamada; Waka Yamada; Mitsuru Muto; Kotaro Kumagai; Akio Ido; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2021-08-26       Impact factor: 1.827

9.  Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model.

Authors:  L Grier Arthur; Keith A Kuenzler; Marshall Z Schwartz
Journal:  J Gastrointest Surg       Date:  2003-12       Impact factor: 3.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.